Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koji Tsuboi

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
International Journal of Particle Therapy|November 28, 2019
Advantages and Limitations in the Use of Combination Therapies with Charged Particle Radiation TherapyKoji Tsuboi
Brain and Nerve = Shinkei Kenkyu No Shinpo|July 22, 2009
[Particle radiotherapy for malignant gliomas]Tetsuya Yamamoto, Koji Tsuboi
Medgenmed : Medscape General Medicine|November 3, 2004
Prevalence of eating disorders: a comparison of Western and non-Western countriesMariko Makino, Koji Tsuboi, Lorraine Dennerstein
Neurologia Medico-Chirurgica|October 17, 2003
Serial neuroimaging of encapsulated chronic intracerebral hematoma with repeated hemorrhage--case reportWataro Tsuruta, Koji Tsuboi, Tadao Nose
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2007
[Differential diagnosis of depressive state]Koji Tsuboi, Ai Iwasaki, Sakura Suga
Neuro-Oncology|March 11, 2003
Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenograftsShingo Takano, Koji Tsuboi, Akira Matsumura, et al.
Brain Tumor Pathology|February 11, 2005
Angiogenesis and antiangiogenic therapy for malignant gliomasShingo Takano, Hiroshi Kamiyama, Koji Tsuboi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 23, 2009
[Nonpharmacologic treatment for insomnia]Yuichi Amano, Ai Iwasaki, Masahiro Hashizume, et al.
Advances in Experimental Medicine and Biology|May 29, 2012
Adoptive cell transfer therapy for malignant gliomasEiichi Ishikawa, Shingo Takano, Tadao Ohno, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2004
Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cellsHiroshi Kamiyama, Shingo Takano, Koji Tsuboi, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
International Journal of Particle Therapy|November 28, 2019
Advantages and Limitations in the Use of Combination Therapies with Charged Particle Radiation TherapyKoji Tsuboi
Brain and Nerve = Shinkei Kenkyu No Shinpo|July 22, 2009
[Particle radiotherapy for malignant gliomas]Tetsuya Yamamoto, Koji Tsuboi
Medgenmed : Medscape General Medicine|November 3, 2004
Prevalence of eating disorders: a comparison of Western and non-Western countriesMariko Makino, Koji Tsuboi, Lorraine Dennerstein
Neurologia Medico-Chirurgica|October 17, 2003
Serial neuroimaging of encapsulated chronic intracerebral hematoma with repeated hemorrhage--case reportWataro Tsuruta, Koji Tsuboi, Tadao Nose
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2007
[Differential diagnosis of depressive state]Koji Tsuboi, Ai Iwasaki, Sakura Suga
Neuro-Oncology|March 11, 2003
Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenograftsShingo Takano, Koji Tsuboi, Akira Matsumura, et al.
Brain Tumor Pathology|February 11, 2005
Angiogenesis and antiangiogenic therapy for malignant gliomasShingo Takano, Hiroshi Kamiyama, Koji Tsuboi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 23, 2009
[Nonpharmacologic treatment for insomnia]Yuichi Amano, Ai Iwasaki, Masahiro Hashizume, et al.
Advances in Experimental Medicine and Biology|May 29, 2012
Adoptive cell transfer therapy for malignant gliomasEiichi Ishikawa, Shingo Takano, Tadao Ohno, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2004
Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cellsHiroshi Kamiyama, Shingo Takano, Koji Tsuboi, et al.
Pageof 13